Skip to main content
Medacta Group SA logo

Medacta Group SA — Investor Relations & Filings

Ticker · MOVE ISIN · CH0468525222 LEI · 506700P2PFU3A3DROC14 SW Manufacturing
Open in API
Filings indexed 199 across all filing types
Latest filing 2020-10-19 Regulatory Filings
Country CH Switzerland
Listing SW MOVE

About Medacta Group SA

https://www.medacta.com/

Medacta Group SA is a medical device company that designs, manufactures, and distributes orthopaedic and neurosurgical products worldwide. Its portfolio focuses on joint replacement, spine surgery, and sports medicine. The company emphasizes innovation in minimally invasive surgical techniques and personalized patient solutions, developed through close collaboration with surgeons. A key component of its business model is the M.O.R.E. Institute, a global medical education platform that provides comprehensive training and support for healthcare professionals. Medacta is recognized for pioneering advanced surgical approaches, such as Kinematic Alignment for total knee replacement, with a focus on improving patient outcomes and healthcare sustainability.

Recent filings

Filing Released Lang Actions
Medacta Expands its Knee Offerings with New SensiTiN System with Low Metal Ion Release
Regulatory Filings Classification · 1% confidence The document is titled "News Details" and is explicitly labeled as a "Media release" announcing the "official launch of the new SensiTiN system in the European market." It discusses a new product (knee implants) and its features, which is typical of a corporate press release regarding product innovation or expansion. This type of announcement, which is not a formal regulatory filing like a 10-K, earnings release (ER), or a specific financial report (IR, AR), is best categorized as a general regulatory announcement or news item that doesn't fit the highly specific financial/governance codes. Given the options, the most appropriate fallback for a general corporate news announcement that is not a formal financial report or governance filing is 'Regulatory Filings' (RNS), as it serves as a general disclosure mechanism.
2020-10-19 English
Medacta Launches M.U.S.T. 2.0 Instrumentation to Expand its Offerings for Spine Pathologies
Report Publication Announcement Classification · 1% confidence The document is titled "Media Release" and announces the launch of a new product, M.U.S.T. 2.0 Instrumentation for spine surgery. It contains corporate news, contact information, and an 'About Medacta' section. This is a standard press release announcing a business development (product launch), not a formal regulatory filing like a 10-K, an earnings report (ER), or a specific financial disclosure. Since there is no specific category for a general product launch announcement, and it is not a formal financial report, it best fits the general regulatory announcement/miscellaneous category, which is RNS (Regulatory Filings), as per the provided definitions where RNS is the fallback for miscellaneous filings that do not neatly fit elsewhere.
2020-10-13 English
Medacta Expands its Knee Portfolio with 3DMetal Femoral Cones for Knee Revision
Regulatory Filings Classification · 1% confidence The document is a 'Media Release' announcing a product expansion (3DMetal Femoral Cones for Knee Revision) following regulatory clearance (FDA and CE marking). It is not a comprehensive financial report (like 10-K or IR), an earnings release (ER), or a transcript (CT). It is a specific announcement regarding product development and regulatory milestones. Since it is a general corporate announcement that doesn't fit the highly specific categories like DIV, DIRS, or MANG, and it is not a formal regulatory filing like a 10-K, the most appropriate general category for a specific, non-financial corporate update that is not a standard report announcement is 'Regulatory Filings' (RNS) as a fallback, although 'LTR' (Legal Proceedings Report) is sometimes used for regulatory clearances, RNS is the best fit for a general news release about product approval/launch that isn't a core financial event.
2020-09-29 English
Medacta Expands its Partial Knee Replacement Solutions with MOTO Lateral Partial Knee System
Regulatory Filings Classification · 1% confidence The document is titled 'Media Release' and announces a new product launch ('MOTO Lateral Partial Knee System') that has recently received regulatory approval (CE marking and FDA clearance). It is a short announcement detailing a business development, not a comprehensive financial report (like 10-K or IR), a transcript (CT), or a formal regulatory filing like a proxy statement or insider trade report. Since it is a news announcement about a business event (product launch/approval), and it doesn't fit the specific categories like ER (Earnings Release) or CAP (Financing Update), the most appropriate general category for a significant, non-financial regulatory/business update that doesn't fit elsewhere is 'Regulatory Filings' (RNS), as it is a general regulatory/news announcement distributed via EQS Group-News.
2020-09-15 English
Publication of 2020 Half Year Results
Earnings Release Classification · 1% confidence The document is titled "Publication of 2020 Half Year Results" and contains detailed financial figures (revenue, EBITDA margin, net profit) and operational highlights for the first semester (H1) of 2020. This content structure is characteristic of a comprehensive financial report covering a period shorter than a full year. The document explicitly mentions the "Medacta 2020 Half-Year Report" and provides a link to download it, but the text itself is a press release summarizing these results, often released concurrently with the full report. Since it covers a half-year period comprehensively, it fits the definition of an Interim / Quarterly Report (IR). It is not just an announcement of the report's publication (RPA) because it contains substantial financial data and analysis, nor is it the full Annual Report (10-K). H1 2020
2020-09-07 English
Medacta Announces Successful Completion of the First Australian Surgery with NextAR TKA Augmented Reality-Based Surgical Platform following TGA Approval
Regulatory Filings Classification · 1% confidence The document is a 'Media Release' dated September 4, 2020, announcing a specific operational achievement: the successful completion of the first Australian surgery using the NextAR TKA platform following regulatory approval (TGA). It contains quotes from the surgeon, hospital CEO, and Medacta's CEO, focusing on the technology and its immediate application. This is not a comprehensive annual report (10-K), an interim financial report (IR), an earnings release (ER), or a formal regulatory filing like a Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). It is a specific announcement about a product/technology milestone, which fits best under the general category of corporate news or a specific operational update. Since there is no specific code for 'Product/Technology Announcement' or 'Operational Update', and the content is a news release about a company event/achievement, it should be classified as a general Regulatory Filing (RNS) as the fallback for miscellaneous corporate news that doesn't fit the highly specific financial/governance categories, although it is clearly a press release.
2020-09-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.